HLA-CeD was more frequent in the control group: 39.34% vs 34.14% in IBD patients, but this difference did not reach statistical significance (Table 2 ).
1
—
—
HLA-CeD was more frequent in the control group: 39.34% vs 34.14% in IBD patients, but this difference did not reach statistical significance (Table 2 ).